Instructions for Bifidumbacterin liquid concentrate 10 ml
One vial contains at least 100 billion live bacteria.
ATC codes
A07FA Biological antidiarrhoeal preparations regulating the balance of intestinal microflora
Clinical-pharmacological groups / Group affiliation
Preparation for regulating the balance of intestinal microflora (probiotic)
Active substance
Bifidobacterium longum
Pharmacotherapy group
MIBP eubiotic
Composition:
Liquid bifidobacteria concentrate Bifidumbacterin, which includes bifidobacteria, which are the most important representatives of human microflora, both in quantitative terms - their specific weight in the composition of microbiocenoses is from 85 to 98%, and in qualitative terms, given their role in maintaining homeostasis of the human body.
The drug Bifidumbacterin is a complex of live active bifidobacteria species: B. bifidum, B. longum, B. adolescentis, grown in a culture medium based on the food collagen hydrolysate "CollAmine®-80" and used as an additional source of microorganisms - bifidobacteria.
Testimony Bifidumbacterin:
- intestinal dysbacteriosis, including after hormone therapy, antibiotics,
- Dysbacteriosis that accompanies various diseases of bile
- Dysbacteriosis that accompanies various diseases of bile
- of the liver, digestive tract, including cholecystitis, pancreatitis, ulcerative
- stomach and duodenal disease;
- Dysbacteriosis in inflammation of the urogenital tract, acute and chronic bronchitis, pneumonia;
- acute intestinal infections (rotavirus infection,
- staphylococcal enterocolitis,
- salmonellosis,
- shigellosis
- Food toxicoinfections and intestinal infections not identified by etiology;
- broken suction syndrome;
- chronic constipation;
- bacterial vaginoses and colpitis;
- allergic diseases characterized by dysbacteriosis;
- Liver, intestinal, pancreatic pathology - pre-operative correction of intestinal microflora.
The drug Bifidumbacterin is a ready-made form.
Before consumption, it is recommended to shake the bottle, the reception is carried out 20-30 minutes before eating.
Rx Multiplicity: 1-2 times a day, adults may take a daily dose once in the morning.
IMPORTANT! Drink ½ cups of water immediately before taking and use probiotic according to recommended dosages.
Dosages Bifidumbacterin:
children from 3 to 12 years old - 1-3 ml
children from 12 years of age and adults - 3-5 ml
The duration of admission is 14-30 days.
It is recommended to consult a doctor before using.
Application for kidney disorders
The drug Bifidumbacterin is allowed to be used in the case of kidney failure
Use in liver disorders
The drug Bifidumbacterin is allowed for use in the case of liver dysfunction
Application in elderly patients
Use is permitted in elderly patients.
Use in children
In children (including premature infants), it is possible to use from the first days of life in medicinal forms intended for this category of patients according to age.
- Nosology Bifidumbacterin (ICD codes)
- A02
- Other salmonella infections
- A03
- Shigellosis
- A04.8
- Other refined bacterial intestinal infections
- A05.0
- Staphylococcal food poisoning
- A08.4
- Viral intestinal infection unspecified
- A09.0
- Other and unspecified gastroenteritis and colitis of infectious origin
- K52.9
- Non-infectious gastroenteritis and colitis unspecified
- K63.8
- Other refined bowel diseases
- N76
- Other inflammatory diseases of the vagina and vulva
- N77.1
- Vaginitis, vulvite and vulvovaginitis for infectious and parasitic diseases classified in other headings
- N89.8
- Other non-inflammatory vaginal diseases
- N95.2
- Postmenopausal atrophic vaginitis
- O91
- Breast infections related to childbirth
- O92.0
- Suction cup
- O92.1
- Nipple fracture related to childbirth
- P23
- Congenital pneumonia
- P36
- Bacterial sepsis of the newborn
- P92.9
- The problem of feeding a newborn is not specified
- Y40
- Systemic antibiotics
- Y42
- Hormones and their synthetic substitutes and antagonists not classified in other rubrics
- Y84.2
- Radiological procedure and radiotherapy
- Z29.8
- Other specific preventive measures
- Z51.4
- Preparatory procedures for follow-up treatment or examination not classified elsewhere
Pharmacological effect Bifidumbacterin:
Pharmgroup: MIBP is a probiotic.
Pharmacy Action: Bifidobacteria play a leading role in the normalization of gut microbiocenosis, maintaining non-specific resistance of the body, improving the processes of absorption and hydrolysis of fats, protein and mineral metabolism, synthesis of biologically active substances, including vitamins.
